Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.54 USD
Change Today -0.11 / -6.67%
Volume 2.4M
ZGNX On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen J. Farr Ph.D.

President and Director, Zogenix, Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 4 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Stephen J. Farr, also known as Steve, Ph.D. Co-founded Zogenix, Inc. in 2006 and has been its President since May 2006. Dr. Farr served as the Chief Operating Officer at Zogenix, Inc. from August 2006 to March 2013. From 1995 to August 2006, he held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation. He served as the Chief Scientific Officer and Senior Vice President for Aradigm Corporation since ...

Read Full Background

Corporate Headquarters*

12400 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-259-1165
Fax: 858-259-1166

Board Members Memberships*

President and Director
Director, Member of Compensation Committee and Member of Audit Committee


De Montfort University
University of Wales

Other Affiliations*

Annual Compensation*

Total Annual Compensation$370,174

Stock Options*

Restricted Stock Awards$75,000
Exercisable Options717,605
Exercisable Options Value$645,842
Unexercisable Options937,395
Unexercisable Options Value$1,290,858
Total Value of Options$1,936,700
Total Number of Options1,655,000

Total Compensation*

Total Annual Cash Compensation$530,174
Total Short Term Compensation$370,174
Other Long Term Compensation$75,000
Total Calculated Compensation$1,402,765
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZGNX:US $1.54 USD -0.11


James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Nasrat Hakim Chief Executive Officer, President and Director
Elite Pharmaceuticals, Inc.
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
Peter D. Staple Chief Executive Officer, President and Director
Corium International, Inc.
Robert S. Radie Chief Executive Officer, President and Director
Egalet Corporation
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOGENIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at